Antibodies to PGRN occur in relevant titers, belong predominantly to the IgG1 subclass (also IgA in IBD), and have a neutralizing effect on plasma PGRN levels, and thus are likely to act in a proinflammatory manner. Here, CD79A is linked to inflammatory bowel disease.